22-02-2026
Cairo Pharmaceuticals (CPCI.CA) Reports 6 Months Results
Source: EGX
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : From 01/07/2025 To 31/12/2025
Net Profit : 268,960,959
F/S Period: From 01/07/2024 To 31/12/2024
Net Comparative Profit : 245,789,794
Audit Status : Reviewed
Source : Cairo Pharmaceuticals
The Financial Statements (18,526 KB)
Market HighLights
EGX30
Market Breadth ***
Declining : Advancing 1.48 : 1
shares
Advancing8937%
Declining13255%
Unchanged177%
Total238
T/O (EGP Mn)662036562744218
Volume (Mn)2483185658244
Sector Ranking by Activity
| Sector Name | T/O (EGP Mn) | Mkt % |
| Financial Services & Electronic Payments | 1,877.47 | 28.36 |
| Real Estate and Hotels | 1,393.11 | 21.04 |
| Industrial, Construction and Materials | 1,000.77 | 15.12 |
| Banks | 591.82 | 8.94 |
| Chemicals | 471.63 | 7.12 |
| Healthcare and Pharmaceuticals | 356.56 | 5.39 |
| Food and Beverage | 254.38 | 3.84 |
| Energy | 172.39 | 2.60 |
| Transportation, Shipping and Logistics | 139.77 | 2.11 |
| Technology, Media and Telecom | 137.60 | 2.08 |
| Other | 114.37 | 1.73 |
| Consumer Discretionary | 94.74 | 1.43 |
| Education | 14.68 | 0.22 |